NNNN
Anbio Biotechnology Class A Ordinary Shares
There isn't enough reported data to score NNNN yet.
NNNN Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Stable | |
| Strong |
NNNN's profitability and balance sheet are currently strong, and its cash flow is stable. There isn't enough data to rate its revenue.
NNNN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 26x | $3.80 | — |
| Cheap | 42x | $6.24 | +64% |
| Fair | 162x | $24.23 | +538% |
| Expensive | 420x | $63.06 | +1559% |
Historical ranges are pointers, not guarantees.
NNNN's PE is 26x, but its earnings don't support one, so it isn't a reliable read right now.
NNNN Forward outlook
There aren't enough analyst estimates for NNNN to show an outlook.
NNNN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.15 | +150% |
| Q4 2024 | $0.06 | -14% |
| Q4 2023 | $0.07 | -73% |
NNNN's earnings per share have fallen from their peak: $0.15 over the past year, against $0.27 in early 2023.
NNNN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $8.6M | +5.6% |
| Q4 2024 | $8.2M | +107% |
| Q4 2023 | $4M | +39% |
| Q3 2023 | $1.8M | -36% |
| Q2 2023 | $3.3M | -63% |
| Q1 2023 | $1.5M | -83% |
NNNN's revenue is growing: $9M last quarter, up 162% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 67% | +20 points |
| Q4 2024 | 24% | -22 points |
| Q4 2023 | 15% | +14 points |
| Q3 2023 | 15% | +14 points |
| Q2 2023 | 46% | -11 points |
| Q1 2023 | 46% | -11 points |
| Q4 2022 | 1.2% | N/A |
| Q3 2022 | 0.6% | N/A |
NNNN's operating margin was 67% last quarter, up 20 points from the same quarter a year ago, near the top of its range since 2022.
NNNN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2023 | -$1.3M | -140% |
| Q3 2023 | -$616.6K | -137% |
| Q2 2023 | $2.3M | +324% |
| Q1 2023 | $1.1M | +96% |
NNNN usually generates cash, though not every quarter: the latest was −$1M, but it generated $1M over the past year.
NNNN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +1.4M shares |
| 1 year | +3.3% | +1.4M shares |
NNNN has 44M diluted shares, up 3.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
NNNN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | -4.1x | Net Cash |
| Q2 2023 | -6.7x | Net Cash |
| Q4 2022 | -0.6x | Net Cash |
NNNN has more cash than debt.
NNNN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.4 | Neutral |
| Stochastic | 5.5 | Oversold |
NNNN's weekly RSI is 32 (neutral) and its Stochastic is 6 (oversold).
NNNN PE vs Healthcare Sector
| Metric | NNNN | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 26x | Same PE |
| PE % | 4 | 72 | 68 pts below |
NNNN is trading at 26x earnings, in line with the Healthcare sector's median of 26x, though its earnings don't support one.
NNNN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.31 | 12% below |
| 20 week MA | $6.89 | 45% below |
| 50 week MA | $18.7 | 80% below |
NNNN is in a downtrend: it's below all three of its weekly moving averages, and 80% below its 50-week average.
NNNN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $5.77 | $33.5 | +481% |
| 2026 YTD | $33.5 | $3.80 | -89% |
NNNN has finished every year since 2025 higher, and it's down 89% so far in 2026.